# Comparative transcriptomic and genomic analysis of tumor cells in the marginal and center regions of tumor nests in human hepatocellular carcinoma

**Authors:** Ziyi Li, Yikai Hu, Zhuotian He, Heyi Xu, Hongyang Wang, Yufei He

PMC · DOI: 10.3389/fcell.2025.1611951 · Frontiers in Cell and Developmental Biology · 2025-07-16

## TL;DR

This study explores how tumor cells in the center and edges of liver cancer nests differ in gene activity, revealing distinct metabolic and immune-related patterns that could guide new therapies.

## Contribution

The study reveals spatially distinct gene expression patterns in tumor nest centers and margins in hepatocellular carcinoma, suggesting functional compartmentalization.

## Key findings

- Tumor nest margins show upregulated immune-related pathways, while centers show metabolism-related pathways.
- Transcriptional differences between tumor nests within individual patients suggest evolutionary heterogeneity.
- Similar spatial gene expression patterns are observed in liver fibrotic nodules.

## Abstract

The tumor nests in solid tumors, including hepatocellular carcinoma (HCC), possess tumor-initiating potential, with the capacity to metastasize and form new metastatic lesions. However, the biological characteristics and heterogeneity of tumor cells at the central and marginal regions of these tumor nests remain poorly understood.

Based on pathological tissue sections, data integration and dimensionality reduction, we defined the boundaries and centers of tumor nests and fibrous nodules within 19 spatial transcriptomics (ST) samples from 8 HCC patients. Differential gene expression was analyzed at the single-unit, sample, patient, and pseudobulk levels, followed by Gene Ontology (GO) enrichment analysis. Additionally, spatial copy number variation (CNV) was inferred using inferCNV, and comparisons were made at the single-unit, sample, patient, and pseudobulk levels.

Ultimately, 24 tumor nests and 15 liver fibrosis nodules were analyzed. The spatial gene expression patterns of the tumor nests exhibited significant heterogeneity, with gene enrichment analysis revealing upregulation of immune-related pathways (e.g., humoral immune response mediated by circulating immunoglobulin; B cell receptor signaling pathway, etc.) at the tumor nest margins and growth/metabolism-related pathways (e.g., sulfur amino acid metabolic process; proteinogenic amino acid metabolic process, etc.) within the tumor nest center. Similar expression patterns were also observed in liver fibrous nodule samples. CNV and clustering analyses demonstrated transcriptional differences between tumor nests within individual patients, suggesting the evolutionary diversity, or heterogeneity, of tumor nests within the same tumor.

Tumor nests exhibit significant transcriptional differentiation along spatial axes: the central regions show high expression of metabolism-related genes, while the marginal regions are enriched in immune-regulatory genes. This pattern is also observed in liver fibrotic nodules. This center-margin functional division may inform rational design of therapeutics that simultaneously modulate metabolism and immune responses.

## Linked entities

- **Diseases:** hepatocellular carcinoma (MONDO:0007256)

## Full-text entities

- **Genes:** RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, SNX20 (sorting nexin 20) [NCBI Gene 124460] {aka SLIC1}, SLC35G2 (solute carrier family 35 member G2) [NCBI Gene 80723] {aka TMEM22}, GGT7 (gamma-glutamyltransferase 7) [NCBI Gene 2686] {aka D20S101, GGT4, GGTL3, GGTL5}, EDN1 (endothelin 1) [NCBI Gene 1906] {aka ARCND3, ET1, HDLCQ7, PPET1, QME}, COL4A1 (collagen type IV alpha 1 chain) [NCBI Gene 1282] {aka BSVD, BSVD1, COL4A1s, PADMAL, RATOR}, EMP3 (epithelial membrane protein 3 (MAM blood group)) [NCBI Gene 2014] {aka YMP}, CCN2 (cellular communication network factor 2) [NCBI Gene 1490] {aka CTGF, HCS24, IBP-8, IGFBP8, KMD, NOV2}, COL1A2 (collagen type I alpha 2 chain) [NCBI Gene 1278] {aka EDSARTH2, EDSCV, OI4}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CLOCK (clock circadian regulator) [NCBI Gene 9575] {aka KAT13D, bHLHe8}, FSTL1 (follistatin like 1) [NCBI Gene 11167] {aka FRP, FSL1, OCC-1, OCC1, tsc36}, MFGE8 (milk fat globule EGF and factor V/VIII domain containing) [NCBI Gene 4240] {aka BA46, EDIL1, HMFG, HsT19888, MFG-E8, MFGM}, COL4A2 (collagen type IV alpha 2 chain) [NCBI Gene 1284] {aka BSVD2, BSVD2A, BSVD2B, ICH, POREN2}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, HAND1 (heart and neural crest derivatives expressed 1) [NCBI Gene 9421] {aka Hxt, Thing1, bHLHa27, eHand}, MAIP1 (matrix AAA peptidase interacting protein 1) [NCBI Gene 79568] {aka C2orf47}, FBXO38 (F-box protein 38) [NCBI Gene 81545] {aka Fbx38, HMN2D, HMND6, MOKA, SP329}, TOP1MT (DNA topoisomerase I mitochondrial) [NCBI Gene 116447]
- **Diseases:** ST (MESH:D008569), inflammatory liver diseases (MESH:D008107), liver cirrhosis (MESH:D008103), precancerous (MESH:D011230), metastasis (MESH:D009362), death (MESH:D003643), HCC tumor (MESH:D006528), Tumor (MESH:D009369), liver (MESH:D017093), cirrhosis (MESH:D005355), chronic (MESH:D002908), CNV (OMIM:610141)
- **Chemicals:** hematoxylin (MESH:D006416), eosin (MESH:D004801), H&amp;E (MESH:D006371), sulfur (MESH:D013455), ST (-), isopentane (MESH:C067038), nitrogen (MESH:D009584), methanol (MESH:D000432)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HCC_1N — Homo sapiens (Human), Hepatitis C infection, Cancer cell line (CVCL_0C52), HCC — Homo sapiens (Human), Hepatocellular carcinoma, Cancer cell line (CVCL_A1AS)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12307378/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12307378/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC12307378/full.md

---
Source: https://tomesphere.com/paper/PMC12307378